Ep 7 - A Conversation with Joseph Truitt (iECURE Inc.)

On this episode of BioBlast, Devin Zitelman interviews Joseph Truitt, CEO of iEcure Inc. Joseph Truitt currently serves as the CEO and Board member of iECURE Inc.

Mr. Truitt previously was CEO of BioSpecifics Technologies Corp., which was recently acquired by Endo Pharmaceuticals. Prior to BioSpecifics, Mr. Truitt was CEO of Achillion Pharmaceuticals, which he joined in 2009 and held positions of increasing responsibility throughout his tenure. Mr. Truitt is Chairman of the board at Larimar Therapeutics and serves on the board of Code BioTherapeutics. Mr. Truitt served as a Captain in the United States Marine Corps. He holds an MBA from Saint Joseph’s University and a BS from LaSalle University.